Analystreport

GlycoMimetics, Inc. (NASDAQ: CBIO) was upgraded by analysts at TD Cowen to a "strong-buy" rating.

Crescent Biopharma, Inc.  (CBIO) 
Last crescent biopharma, inc. earnings: 11/7 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: catalystbiosciences.com/investors